The enzyme protein found naturally in the body alleviated pain eight times more effectively than morphine. Research findings are published this week as the cover story of the esteemed Neuron journal.
Professor Pirkko Vihko from the Department of Biological and Environmental Sciences of the University of Helsinki has conducted research on the Prostatic Acid Phosphatase (PAP) enzyme for more than 30 years. As the name indicates, the prostate contains plenty of this enzyme.
Last year, Vihko's research team described the membrane form of the enzyme and showed that it is present not only in the prostate, but in many other cells and organs as well. The PAP enzyme exists, for example, in pain-sensing nerves, but it has disappeared from damaged nerves.
For the research project presented in the Neuron journal, Vihko and her team prepared a knockout mouse model with the PAP enzyme knocked out. Together with Mark Zylka's team from the University of North Carolina they showed that these mice had an increased sensitivity for pain caused by inflammation and neural damage. The reason for the sensitivity was the lack of the PAP enzyme. Enzyme protein replacement treatment removed pain effectively – eight times more so than morphine. Clinical research will begin next.
Research teams also determined the mechanism that the acid phosphatase of the prostate uses to regulate pain alleviation. In an organism, the enzyme generates adenosine that controls the experience of pain through the adenosine receptor. Vihko’s team will prepare new publications that describe the entirely new effective areas of the enzyme.
Kirsikka Mattila | alfa
Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign
Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences